\
&
Contact us
\
&
Contact us
Published on | 3 months ago
Programmes Agro-Food, Environment MissionsThe pathways2resilience initiative is linked to the mission on adaptation to climate change and is governed by the KIC climate, which operates as a fully independent unit since the beginning of this year. It focuses mainly on helping local and regional authorities to become forerunners in tackling the societal changes resulting from climate change.
The second call for applications is open since the 15th of May and will close on the 20th of August 2025. 61 new subgrantees will be selected, receiving financial support of (up to) 210,000€, along with a capacity-building program.
All information can be found here.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Security Digital, Industry & Space Cybersecurity
The NIS Cooperation Group has launched a survey to collect feedback aimed at guiding the future steps towards implementing quantum-safe cryptography in Europe. This initiative follows the release of the "Coordinated Implementation Roadmap for the Transition to Post-Quantum Cryptography (PQC)". Quantum computing poses significant challenges to data... read more
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
